ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marek A. Deja
Kazimierz Widenka
Stanislaw Wos
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deja, M. A.
Right arrow Articles by Wos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deja, M. A.
Right arrow Articles by Wos, S.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2006;81:1408-1416
© 2006 The Society of Thoracic Surgeons


Original article: Cardiovascular

Diazoxide Provides Maximal KATP Channels Independent Protection if Present Throughout Hypoxia

Marek A. Deja, MD a , * , Krzysztof S. Golba, MD, PhD b , Marcin Malinowski, MD a , Kazimierz Widenka, MD a , Jolanta Biernat, MD b , Dariusz Szurlej, MD, PhD c , Stanislaw Wos, MD, PhD a

a Second Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland
b Department of Cardiology, Medical University of Silesia, Katowice, Poland
c Department of Anesthesiology, Medical University of Silesia, Katowice, Poland

Accepted for publication November 28, 2005.

* Address correspondence to Dr Deja, Second Department of Cardiac Surgery, Medical University of Silesia, Ul. Ziolowa 47, Katowice 40-635, Poland (Email: narizol{at}slam.katowice.pl).

BACKGROUND: It is not clear what the optimal timing of diazoxide administration for cardioprotection in human myocardium is. We aimed to establish it. We next checked whether protection depended on adenosine triphosphate (ATP)–inhibited potassium (KATP) channels.

METHODS: Isolated human right atrial trabeculae were subjected to 90-minute hypoxia and 120-minute reoxygenation in vitro, followed by adding 10-4 M norepinephrine. Diazoxide (100 µM) was added (1) as a 10-minute preconditioning signal with 10-minute washout before hypoxia or (2) 10-minute pretreatment without washout before hypoxia or (3) throughout hypoxia or (4) 10 minutes before and throughout hypoxia or (5) during the first 20 minutes of reoxygenation only. In the control, no diazoxide was added. In another set of experiments, diazoxide (100 µM) was present throughout hypoxia in control, while we tried to inhibit its protective effect with glibenclamide (1, 10, 100 µM) or 5-hydroxydecanoate (100 µM).

RESULTS: The presence of diazoxide throughout hypoxia improved recovery of contractility during reoxygenation, allowed for significant response to norepinephrine at the end of reoxygenation, prevented "ischemic contracture" development, and reduced release of troponin I to tissue bath during hypoxia. Adding diazoxide 10 minutes before hypoxia conferred significantly weaker protective effects in all the above respects. We failed to show a protective effect of diazoxide used as a preconditioning signal or during reoxygenation. Neither 5-hydroxydecanoate nor glibenclamide significantly influenced protective effects of diazoxide added during hypoxia.

CONCLUSIONS: Administration of diazoxide throughout hypoxia provided maximal protective effect, suggesting that diazoxide may be an important adjunct to cardioplegic solution. The protection offered by diazoxide used during hypoxia appears independent of its influence on KATP channels.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. A. Deja, M. Malinowski, K. S. Golba, M. Kajor, T. Lebda-Wyborny, D. Hudziak, W. Domaradzki, D. Szurlej, A. Bonczyk, J. Biernat, et al.
Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: A double-blind randomized feasibility study of diazoxide-supplemented cardioplegia
J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. S. Al-Dadah, R. K. Voeller, R. B. Schuessler, R. J. Damiano Jr, and J. S. Lawton
Maintenance of Myocyte Volume Homeostasis During Stress by Diazoxide is Cardioprotective
Ann. Thorac. Surg., September 1, 2007; 84(3): 857 - 862.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. J. Chambers
Invited commentary
Ann. Thorac. Surg., April 1, 2006; 81(4): 1416 - 1416.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.